Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

NCS Multistage Holdings (NCSM) EBITDA (2016 - 2025)

NCS Multistage Holdings (NCSM) has 10 years of EBITDA data on record, last reported at $8.7 million in Q4 2025.

  • For Q4 2025, EBITDA rose 154.03% year-over-year to $8.7 million; the TTM value through Dec 2025 reached $15.5 million, up 148.58%, while the annual FY2025 figure was $15.5 million, 148.58% up from the prior year.
  • EBITDA reached $8.7 million in Q4 2025 per NCSM's latest filing, up from $3.6 million in the prior quarter.
  • Across five years, EBITDA topped out at $8.7 million in Q4 2025 and bottomed at -$6.2 million in Q2 2023.
  • Average EBITDA over 5 years is $1.1 million, with a median of $2.5 million recorded in 2021.
  • The widest YoY moves for EBITDA: up 233.15% in 2023, down 59.54% in 2023.
  • A 5-year view of EBITDA shows it stood at $2.3 million in 2021, then increased by 20.5% to $2.7 million in 2022, then tumbled by 59.54% to $1.1 million in 2023, then surged by 211.81% to $3.4 million in 2024, then surged by 154.03% to $8.7 million in 2025.
  • Per Business Quant database, its latest 3 readings for EBITDA were $8.7 million in Q4 2025, $3.6 million in Q3 2025, and -$2.2 million in Q2 2025.